Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan
· Delayed Price · Currency is TWD 220.00
-1.00 (-0.45%)
Jun 27, 2025, 2:38 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Pharmaceuticals | 16.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | 16.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 94.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -27.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 94.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -27.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Other | 2.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 7.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 6.81B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 15.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 5.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 5.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan | 2.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | 67.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 2.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 7.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|